
At FDAQRC, our Inspection Readiness Services are designed to help pharmaceutical, biotech, and medical device companies view inspections not as obstacles, but as opportunities to strengthen quality and compliance. With comprehensive support spanning proactive preparation, real-time inspection guidance, and post-inspection remediation, our team ensures clients are equipped to meet FDA, EMA, and MHRA expectations with confidence. Leading these efforts is former FDA Investigator and Compliance Officer Randall Morris, who serves as FDAQRC’s Inspection Readiness Advisor. Randall brings extensive experience in clinical care, research, auditing, and regulatory affairs, having conducted numerous site audits and compliance reviews during his tenure at the FDA. Since joining FDAQRC, he has used his regulatory insight to help clients identify and close compliance gaps, train staff, and develop sustainable quality systems that promote continuous inspection readiness.
Randall brings extensive experience in clinical care, research, auditing, and regulatory affairs with a strong focus on inspection readiness. Before joining FDAQRC in 2019, he served as a Clinical Nurse, Clinical Research Coordinator, FDA Investigator, and FDA Compliance Officer, conducting numerous site audits and compliance reviews. At FDAQRC, he uses his FDA expertise to help clients strengthen quality systems and stay inspection-ready. He holds an MSN in Clinical Research Management from Duke University and a BSN from Old Dominion University.
Our dedicated team is here to promptly respond to your inquiries, provide answers, and schedule meetings at your convenience.
